ACURA PHARMACEUTICALS, INC: auditor change — Acura Pharmaceuticals appoints PKF Mueller as new independent auditor for FY2022

ACURA PHARMACEUTICALS, INC

Audit Committee approved PKF Mueller as new independent registered public accounting firm on July 21, 2023.
PKF Mueller formally engaged on July 27, 2023 to audit fiscal year ending December 31, 2022.
No consultations with PKF Mueller on accounting principles or audit opinions prior to appointment.
No reportable disagreements or reportable events with predecessor auditor exist.

item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

ACURA PHARMACEUTICALS, INC engaged PKF Mueller as its auditor.

Action: engagement
Auditor: PKF Mueller

Exact text from the filing

On July 21, 2023, the Audit Committee approved the appointment of PKF Mueller as the Company’s new independent registered public accounting firm, to perform independent audit services for the fiscal year ending December 31, 2022. PKF Mueller was formally engaged on July 27, 2023.

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001104659-23-085172

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.